Huadong Medicine Co., Ltd
000963
Rang in aandelen
#2706
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Aandeelprijs
$3.89
Marktkapitalisatie
$6.83B
Verandering (1 dag)
-2.22%
Verandering (1 jaar)
-30.58%
Land
CN
Handel Huadong Medicine Co., Ltd (000963)
Categorie
Healthcare
Koersgeschiedenis voor Huadong Medicine Co., Ltd (000963)
Hoogste slotkoers: $3.87 op 2026-10-01
Laagste slotkoers: $0.11 op 2005-07-01
Laagste slotkoers: $0.11 op 2005-07-01
Koersgeschiedenis van Huadong Medicine Co., Ltd van 2005 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -16.32% |
| 2025 | 15.27% |
| 2024 | -10.20% |
| 2023 | -11.84% |
| 2022 | 10.60% |
| 2021 | 31.18% |
| 2020 | 30.65% |
| 2019 | -4.14% |
| 2018 | -18.32% |
| 2017 | 48.88% |
| 2016 | -16.87% |
| 2015 | 45.58% |
| 2014 | 20.43% |
| 2013 | 34.39% |
| 2012 | 20.98% |
| 2011 | -11.01% |
| 2010 | 82.92% |
| 2009 | 87.78% |
| 2008 | -28.69% |
| 2007 | 221.39% |
| 2006 | 61.19% |
| 2005 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
